Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$14.54 - $16.7 $3,751 - $4,308
258 Added 0.23%
112,833 $1.76 Million
Q1 2022

May 16, 2022

SELL
$15.53 - $17.95 $8,696 - $10,052
-560 Reduced 0.49%
112,575 $1.77 Million
Q4 2021

Feb 14, 2022

BUY
$15.28 - $17.56 $40,874 - $46,973
2,675 Added 2.42%
113,135 $1.84 Million
Q3 2021

Nov 15, 2021

BUY
$15.92 - $17.61 $5,014 - $5,547
315 Added 0.29%
110,460 $1.82 Million
Q2 2021

Aug 16, 2021

SELL
$14.72 - $18.22 $2,723 - $3,370
-185 Reduced 0.17%
110,145 $1.92 Million
Q1 2021

May 17, 2021

BUY
$15.27 - $17.41 $260,658 - $297,188
17,070 Added 18.3%
110,330 $1.7 Million
Q4 2020

Feb 16, 2021

BUY
$13.63 - $15.95 $345,724 - $404,571
25,365 Added 37.36%
93,260 $1.44 Million
Q3 2020

Nov 16, 2020

SELL
$14.91 - $16.52 $55,688 - $61,702
-3,735 Reduced 5.21%
67,895 $1.01 Million
Q2 2020

Aug 14, 2020

BUY
$14.59 - $18.42 $1.05 Million - $1.32 Million
71,630 New
71,630 $1.2 Million

Others Institutions Holding ALPMY

About Astellas Pharma Inc Unsponsore


  • Ticker ALPMY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,827,069,952
  • Market Cap $17.9B
More about ALPMY
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.